Subject(s)
Mycetoma/diagnostic imaging , Nocardia Infections/diagnostic imaging , Nocardia/isolation & purification , Ovary/diagnostic imaging , Pelvic Inflammatory Disease/diagnostic imaging , Reproductive Tract Infections/diagnostic imaging , Acute Pain/etiology , Acute Pain/prevention & control , Adult , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/adverse effects , Anti-Inflammatory Agents/therapeutic use , Back Pain/etiology , Back Pain/prevention & control , Diagnosis, Differential , Drug Monitoring , Drug Therapy, Combination/adverse effects , Female , Humans , Mycetoma/drug therapy , Mycetoma/microbiology , Mycetoma/pathology , Nocardia/drug effects , Nocardia Infections/drug therapy , Nocardia Infections/microbiology , Nocardia Infections/pathology , Ovary/drug effects , Ovary/microbiology , Ovary/pathology , Pelvic Inflammatory Disease/drug therapy , Pelvic Inflammatory Disease/microbiology , Pelvic Inflammatory Disease/pathology , Prednisone/adverse effects , Prednisone/therapeutic use , Reproductive Tract Infections/drug therapy , Reproductive Tract Infections/microbiology , Reproductive Tract Infections/pathology , Treatment Outcome , Weight Loss , Young AdultABSTRACT
Se presenta el caso de una mujer de 42 años de edad que inicia manifestaciones neurológicas caracterizadas por parestesias y hemiparesia corporal derecha. Con importante duda diagnóstica en su debut, pero la características de las lesiones (localización en corteza, ausencia en sustancia -lanca, falta de distribución arterial), serología positiva para LES y proteinuria, determino el diagnóstico de Lupus eritematoso Sistémico Neuropsiquiátrico (LENSP). El propósito de este manuscrito es informar la baja prevalencia (menor al 4%)¹ de esta manifestación y como representa un reto diagnóstico.
The case of a 42-year-old woman who presented neurologic symptoms characterized by paresthesias and right hemiparesis is presented here. Although the diagnosis was difficult at the beginning; yet, the features of the lesions (located in the cerebral cortex but not in the white matter; no arterial distribution), positive serology for SLE and proteinuria, determined the diagnosis of Neuropsychiatric systemic lupus erythematosus. The purpose of this work is to inform about the low prevalence (<4%) of the disease and how it is a diagnostic challenge.